This synergy is particularly important for enhancing treatment outcomes while minimizing potential side effects
[77] Drug-induced SLE Drug-induced lupus erythematosus is a (generally) reversible condition that usually occurs in people being treated for a long-term illness
Patients with type 2 diabetes and obesity represent another population who may derive metabolic advantages, though it is important to note that Zepbound is not FDA-approved for diabetes treatment (tirzepatide is marketed as Mounjaro for diabetes management)
Bariatric surgery remains the gold standard for severe obesity (BMI 40 or 35 with complications)
These were observable as the spontaneous release of NO [67,68], as a counteraction of the adverse effect of a NOS blockade (i.e., L-NAME hypertension and pro-thrombotic effect), a counteraction of the adverse effect of NOS overstimulation (i.e., L-arginine hypotension and anti-thrombotic effect) [67,69], as control of vasomotor tone and as the activation of the Src-Caveolin-1-eNOS pathway [60,61]